DrugPatentWatch Database Preview
Synthon Pharms Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for SYNTHON PHARMS, and when can generic versions of SYNTHON PHARMS drugs launch?
SYNTHON PHARMS has twelve approved drugs.
There is one US patent protecting SYNTHON PHARMS drugs. There are three tentative approvals on SYNTHON PHARMS drugs.
There are five patent family members on SYNTHON PHARMS drugs in five countries and thirty-four supplementary protection certificates in ten countries.
Summary for Synthon Pharms
| International Patents: | 5 |
| US Patents: | 1 |
| Tradenames: | 10 |
| Ingredients: | 10 |
| NDAs: | 12 |
Drugs and US Patents for Synthon Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synthon Pharms | AMLODIPINE BESYLATE | amlodipine besylate | TABLET;ORAL | 077080-001 | Jun 27, 2007 | DISCN | No | No | Start Trial | Start Trial | |||||
| Synthon Pharms | AMLODIPINE BESYLATE | amlodipine besylate | TABLET;ORAL | 077080-002 | Jun 27, 2007 | DISCN | No | No | Start Trial | Start Trial | |||||
| Synthon Pharms | LEVOCETIRIZINE DIHYDROCHLORIDE | levocetirizine dihydrochloride | TABLET;ORAL | 090229-001 | Nov 26, 2010 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Premature patent expirations for SYNTHON PHARMS
Expiration due to failure to pay maintenance fee
| Patent Number | Expiration Date |
|---|---|
| Start Trial | Start Trial |
International Patents for Synthon Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Norway | 20042539 | Start Trial |
| Argentina | 037565 | Start Trial |
| European Patent Office | 1448197 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Synthon Pharms Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0663828 | C300085 | Netherlands | Start Trial | PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103 |
| 0503785 | C300375 | Netherlands | Start Trial | PRODUCT NAME: COMBINATIE VAN OLMESARTAN MEDOXOMIL, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT EN AMLODIPINEBESILAAT; REGISTRATION NO/DATE: RVG100984, RVG100986-87, RVG100989-91, RVG100993-95 20080819 |
| 0296749 | 97C0023 | France | Start Trial | PRODUCT NAME: ANASTROZOLE, EVENTUELLEMENT SOUS LA FORME D UN SEL D ADDITION ACCEPTABLE EN MEDECINE PHARMACEUTIQUE; NAT REG. NO/DATE: NL 21126 19961227; FIRST REG.: 12619/0106 19950811 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
